+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Urokinase plasminogen activator is an independent prognostic factor for muscle invasive bladder cancer



Urokinase plasminogen activator is an independent prognostic factor for muscle invasive bladder cancer



Journal of Urology 157(4 Suppl. ): 51




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 034144163

Download citation: RISBibTeXText


Related references

The urokinase type plasminogen activator upa is an independent prognostic factor in breast cancer. Journal of Cancer Research & Clinical Oncology 116(Suppl. Part 1): 47, 1990

Urokinase-Type Plasminogen Activator Antigen As A Prognostic Factor In Bladder Cancer. The Japanese Journal of Urology 84(9): 1624-1628, 1993

Urokinase-type plasminogen activator antigen as a prognostic factor in bladder cancer. Nihon Hinyokika Gakkai Zasshi. Japanese Journal of Urology 84(9): 1624-1628, 1993

The content of urokinase-type plasminogen activator antigen as a prognostic factor in urinary bladder cancer. International Journal of Cancer 50(6): 871-873, 1992

Urokinase plasminogen activator receptor on invasive cancer cells: a prognostic factor in distal gastric adenocarcinoma. International Journal of Cancer 131(4): E329-E336, 2012

The prognostic value of vascular endothelial growth factor, urokinase plasminogen activator and plasminogen activator inhibitor-1 in node-negative breast cancer. International Journal of Biological Markers 19(4): 282-288, 2005

Urokinase-type plasminogen activator is a marker of aggressive phenotype and an independent prognostic factor in mismatch repair-proficient colorectal cancer. Human Pathology 41(1): 70-78, 2009

Urokinase plasminogen activator, a strong independent prognostic factor in breast cancer, analysed in steroid receptor cytosols with a luminometric immunoassay. European Journal of Cancer 32A(5): 793-801, 1996

Vascular endothelial growth factor and urokinase plasminogen activator are independent prognostic factors for distant recurrences in premenopausal node-negative breast cancer. Breast Cancer Research & Treatment 57(1): 98, 1999

Urokinase-plasminogen activator, a new and independent prognostic marker in breast cancer. Cancer Research 50(21): 6827-6829, 1990

Plasminogen- and colony-stimulating factor-1-associated markers in bladder carcinoma: diagnostic value of urokinase plasminogen activator receptor and plasminogen activator inhibitor type-2 using immunocytochemical analysis. Urological Research 30(5): 301-309, 2002

Urokinase plasminogen activator a strong and independent prognostic marker in breast cancer. Fibrinolysis 6(Suppl. 4): 55-57, 1992

Prognostic value of urokinase-type plasminogen activator in patients with superficial bladder cancer. Urology 47(1): 34-37, 1996

Prognostic significance of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor (PAI-1) in patients with primary invasive ductal breast carcinoma - a 7.5-year follow-up study. Tumori 97(4): 532-539, 2012

Urokinase-type plasminogen activator and plasminogen activator inhibitor-1 as a prognostic factor in human colorectal carcinomas. Hepato-Gastroenterology 46(28): 2299-2308, 1999